The fourth domain protein, Vanin-1, which is a unique protein that balances inflammation, metabolic diseases, and oxidative stress, was highly expressed in the control group but showed negligible expression in CML (p <0.0001). This evidence concerns the gene VNN1 and chronic myelogenous leukemia, BCR-ABL1 positive.